TotalMarketCap

QuidelOrtho

QDELNasdaq United StatesHealth CareBiotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$886.337 M

$12.93 -9.93%

Close of 6 Nov 2026

As of 6 Nov 2026, QuidelOrtho (QDEL) has a market capitalization of $886.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$2.73B

#972 by revenue

Earnings

-$1.13B

Loss-making

Shares outstanding

68,612,588

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: In Vitro & In Vivo Diagnostic Substances, ranked by market cap

All 19 →
  1. #5Celldex TherapeuticsCLDX$2.22B
  2. #6Intellia TherapeuticsNTLA$1.56B
  3. #7QuidelOrthoQDEL$886.3M
  4. #8Achieve Life SciencesACHV$658.1M
  5. #9Myriad GeneticsMYGN$597.3M

What if QuidelOrtho were worth as much as…

Open the what-if tool →

Gold $28.2T

$411,763.73

Per share 31,858× higher

Bitcoin $1.53T

$22,279.82

Per share 1,724× higher

Apple $5.02T

$73,142.56

Per share 5,659× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for QuidelOrtho are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.